Skip to main content
. 2012 Mar 14;41(4):541–545. doi: 10.1093/ageing/afs038

Table 1.

Baseline characteristics in overall cohort as well as comparisons by elevated (≥3 mg/l) versus low (<3 mg/l) HsCRP levels

Overall Elevated HsCRP Low HsCRP P-value*
n 624 224 400
Age, mean (SD), years 80.34 (5.37) 79.97 (5.57) 80.55 (5.37) 0.176
Education years, mean (SD), years 14.06 (3.47) 13.71 (3.54) 14.26 (3.32) 0.077
Female (%) 62 65 60 0.269
Low physical activity, % 43 44 42 0.641
Medication usea, (%) 45 39 48 0.031
Falls last year, (%) 26 27 25 0.643
Blessed test score, mean (SD) 2.04 (2.19) 2.27 (2.13) 1.91 (2.22) 0.007
Gait velocity, mean (±SD), cm/s 95.52 (22.90) 92.77 (24.20) 97.06 (22.02) 0.029
Medical illnesses
 Diabetes, % 17 20 15 0.136
 Heart failure, % 2 4 2 0.154
 Hypertension, % 63 66 62 0.311
 Depression, % 11 14 10 0.147
 Stroke, % 10 12 9 0.268
 Parkinson's disease, % 1 0 1 0.302
 Chronic lung disease, % 7 11 4 0.002
 Angina, % 9 11 8 0.305
 Myocardial infarction, % 5 3 7 0.071
 Severe arthritis, % 5 4 6 0.414
 Illness index (range 0–10) 1.31 (1.04) 1.44 (1.07) 1.24 (1.01) 0.024
 Laboratory test
 Total cholesterol, mean (SD) 189.11 (39.58) 193.99 (38.76) 186.39 (39.82) 0.010

aMedications include statins, prednisone, non-steroidal anti-inflammatory drugs or oestrogens.

*P-values are for comparison of subject with high HsCRP versus rest, and derived from Chi-square or Fisher's exact test for categorical variables and the Wilcoxon rank sum test for continuous variables.